Biopolym. Cell. 2012; 28(5):381-388.
http://dx.doi.org/10.7124/bc.000074
Molecular Biomedicine
The peculiarities of gene expression of medullary breast carcinoma tumor-associated antigensin different types of breast tumors
1, 2Shyian M. A., 1, 2Kostianets O. I., 1Tsuvariev O. Yu., 1Stolyaruk A. V., 3Antoniuk S. S., 1Filonenko V. V., 1Kiyamova R. G.
  1. Institute of Molecular Biology and Genetics, NAS of Ukraine
    150, Akademika Zabolotnoho Str., Kyiv, Ukraine, 03680
  2. Educational and Scientific Center "Institute of Biology",
    Taras Shevchenko National University of Kyiv
    64/13, Volodymyrska Str., Kyiv, Ukraine, 01601
  3. Dnipropetrovs'k Clinical Oncological Center
    21, Kosmichna Str., Dnipropetrovs'k, Ukraine, 49100

Abstract

Aim. To investigate gene expression profile of human medullary breast carcinoma’s tumor-associated antigens in different histological types of breast tumors. To analyze a correlation between alterations in gene expression level and induction of immune response against the corresponding antigens. Methods. Real-time polymerase chain reaction. Results. Differential gene expression profile of 6 (RAD50, HMGN2, RBPJ, PABPC4, BRAP, DEK) medullary breast carcinoma tumor-associated antigens have been revealed in breast tumors of different histological types. Correlation between changes in tumor-associated antigens gene expression level and induction of immune response has not been found. Conclusions. The genes of human medullary breast carcinoma tumor-associated antigens with differential expression profile in different histological types of breast tumors are potential diagnostic markers of breast cancer. Alteration of tumor-associated antigens gene expression level is not a prelude to an immune response against their corresponding protein products.
Keywords: medullary breast carcinoma, tumor-associated antigens, immunoreactivity
Full text: (PDF, in English) (PDF, in Ukrainian)

References

[1] Weigelt B., Reis-Filho J. S. Histological and molecular types of breast cancer: is there a unifying taxonomy? Nat. Rev. Clin. Oncol. 2009 6, N 12:718–730.
[2] Brass N., Racz A., Bauer C., Heckel D., Sybrecht G., Meese E. Role of amplified genes in the production of autoantibodies Blood 1999 93, N 7:2158–2166.
[3] Scanlan M. J., Gout I., Gordon C. M., Williamson B., Stockert E., Gure A. O., Jager D., Chen Y. T., Mackay A., O'Hare M. J., Old L. J. Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression Cancer Immun 2001 1:4.
[4] Chen Y. T., Scanlan M. J., Venditti C. A., Chua R., Theiler G., Stevenson B. J., Iseli C., Gure A. O., Vasicek T., Strausberg R. L., Jongeneel C. V., Old L. J., Simpson A. J. Identification of cancer/testis-antigen genes by massively parallel signature sequencing Proc. Natl Acad. Sci. USA–2005 102, N 22:7940–7945.
[5] Rapberger R., Perco P., Sax C., Pangerl T., Siehs C., Pils D., Bernthaler A., Lukas A., Mayer B., Krainer M. Linking the ovarian cancer transcriptome and immunome BMC Syst. Biol 2008 2–P. 2.
[6] Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal. Biochem 1987 162, N 1:156–159.
[7] Pfaffl M. W. A new mathematical model for relative quantification in real-time RT-PCR Nucleic Acids Res 2001 29, N 9 e45.
[8] Kostianets O. I., Shyian M. A., Antoniuk S. V., Demidov S. V., Filonenko V. V., Kiyamova R. G. Allogeneic screening of tumorassociated antigens of human breast cancer Biotekhnologiya 2012 5, N 4:55–64.
[9] Scanlan M. J., Welt S., Gordon C. M., Chen Y. T., Gure A.O., Stockert E., Jungbluth A. A., Ritter G., Jager D., Jager E., Knuth A., Old L. J. Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets Cancer Res 2002 62, N 1:4041– 4047.
[10] Kiyamova R., Kostianets O., Malyuchik S., Filonenko V., Usenko V., Gurtovyy V., Khozayenko Y., Antonuk S., Old L., Gout I. Identification of tumor-associated antigens from medullary breast carcinoma by a modified SEREX approach Mol. Biotechnol 2010 46, N 2:105–112.
[11] Kostianets O., Shyian M., Demidov S., Antoniuk S., Gout I., Filonenko V., Kiyamova R. Serological analysis of SEREX-defined medullary breast carcinoma-associated antigens Cancer Invest 2012 30, N 7:519–527.
[12] Bartkova J., Tommiska J., Oplustilova L., Aaltonen K., Tamminen A., Heikkinen T., Mistrik M., Aittomaki K., Blomqvist C., Heikkila P., Lukas J., Nevanlinna H., Bartek J. Aberrations of the MRE11-RAD50-NBS1 DNA damage sensor complex in human breast cancer: MRE11 as a candidate familial cancerpredisposing gene Mol. Oncol 2008 2, N 4:296–316.
[13] Privette Vinnedge L. M., McClaine R., Wagh P. K., Wikenheiser-Brokamp K. A., Waltz S. E., Wells S. I. The human DEK oncogene stimulates b-catenin signaling, invasion and mammosphere formation in breast cancer Oncogene 2011 30, N 24:2741–2752.
[14] Riveiro-Falkenbach E., Soengas M. S. Control of tumorigenesis and chemoresistance by the DEK oncogene Clin. Cancer Res 2010 16, N 11:2932–2938.
[15] Fulcher A. J., Roth D. M., Fatima S., Alvisi G., Jans D. A. The BRCA-1 binding protein BRAP2 is a novel, negative regulator of nuclear import of viral proteins, dependent on phosphorylation flanking the nuclear localization signal FASEB J 2010 24, N 5:1454–1466.
[16] Yin B. W., Kiyamova R., Chua R., Caballero O. L., Gout I., Gryshkova V., Bhaskaran N., Souchelnytskyi S., Hellman U., Filonenko V., Jungbluth A. A., Odunsi K., Lloyd K. O., Old L. J., Ritter G. Monoclonal antibody MX35 detects the membrane transporter NaPi2b (SLC34A2) in human carcinomas Cancer Immun 2008 8:3.
[17] Lituiev D. S., Kiyamova R. G. Mutations in the gene of human type IIb sodium-phosphate cotransporter SLC34A2 Biopolym. Cell 2010 26, N 1:13–22
[18] Gryshkova V. S., Filonenko V.V., Kiyamova R. G. Inhibition of sodium-dependent phosphate transporter NaPi2b function with Mx35 antibody Biopolym. Cell 2011 27, N 3:193–198.
[19] Chen D. R., Chien S. Y., Kuo S. J., Teng Y. H., Tsai H. T., Kuo J. H., Chung J. G. SLC34A2 as a novel marker for diagnosis and targeted therapy of breast cancer Anticancer Res 2010 30, N 10:4135–4140.
[20] Gygi S. P., Rochon Y., Franza B. R., Aebersold R. Correlation between protein and mRNA abundance in yeast Mol. Cell. Biol 1999 19, N 3:1720–1730.